Franklyn G. Prendergast - Aug 19, 2021 Form 4 Insider Report for NeuBase Therapeutics, Inc. (NBSE)

Role: Director
Signature: /s/ Sam Backenroth, as attorney-in-fact for Franklyn G. Prendergast
Stock symbol: NBSE
Transactions as of: Aug 19, 2021
Transactions value $: $0
Form type: 4
Date filed: 9/17/2021, 04:17 PM
Previous filing: Jun 21, 2021
Next filing: Nov 8, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NBSE	Stock option (right to buy)	Award	$0	+38.1K		$0.00	38.1K	Aug 19, 2021	Common Stock	38.1K	$3.36	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the total shares shall vest on the first anniversary of August 19, 2021, and the remaining shares shall vest on an equal monthly basis over the following 36 months.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.